ArticleCancer biomarkers : section A of Disease markers2020

Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.

Emre Özgür et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.